Why the study?
Does genetic deletion of eNOS or iNOS alter neointimal formation and constrictive remodeling following carotid artery ligation in mice?
Does genetic deletion of eNOS or iNOS alter neointimal formation and constrictive remodeling following carotid artery ligation in mice?
eNOS and iNOS provide distinct vasculoprotective effects in vivo, with eNOS inhibiting neointimal formation and iNOS suppressing constrictive remodeling after blood flow disruption.
Isoform-specific NOS effects on remodeling are delineated in mice; leaves open translation to human restenosis prevention.
NO is known to have several important vasculoprotective actions. Although NO is synthesized by 3 different NO synthase (NOS) isoforms, the vasculoprotective action of individual NOS isoforms remains to be clarified. Permanent ligation of the left common carotid artery was performed in control, endothelial NOS (eNOS) knockout (eNOS-KO), and inducible NOS (iNOS) knockout (iNOS-KO) mice. Four weeks after the procedure, neointimal formation and reduction of cross-sectional vascular area (constrictive remodeling) were noted in the left carotid artery. In the eNOS-KO mice, the extent of neointimal formation was significantly larger than in the control or iNOS-KO mice, whereas the extent of vascular remodeling was the highest in the iNOS-KO mice compared with other 2 strains. Antiplatelet therapy with aspirin or antihypertensive treatment with bunazosin failed to inhibit the accelerated neointimal formation in the eNOS-KO mice. These results indicate that eNOS and iNOS have different vasculoprotective actions against the vascular lesion formation caused by blood flow disruption in vivo: NO derived from eNOS inhibits neointimal formation, whereas NO derived from iNOS suppresses the development of constrictive remodeling.
No takes yet. Share an insight, caveat, or question.
Yogo et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: